Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$620K Buy
1,713
+110
+7% +$37.7K 0.28% 63
2026
Q1
$564K Hold
1,603
0.32% 56
2025
Q4
$525K Hold
1,603
0.29% 66
2025
Q3
$452K Hold
1,603
0.24% 77
2025
Q2
$448K Hold
1,603
0.27% 66
2025
Q1
$499K Hold
1,603
0.32% 58
2024
Q4
$418K Hold
1,603
0.24% 71
2024
Q3
$517K Hold
1,603
0.33% 54
2024
Q2
$501K Buy
+1,603
New +$471K 0.3% 54

Other funds holding AMGN

Cromwell Holdings's AMGN Position: Q2 2026 in Review

Cromwell Holdings increased its Amgen (AMGN) stake by 6.9% in Q2 2026, buying an estimated $37.7K and bringing the position to 1,713 shares worth $620K. The position accounts for 0.28% of the portfolio, ranked #63.

Cromwell Holdings first reported a position in AMGN in Q2 2024 and has held it in 9 quarters since. 937 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Cromwell Holdings held 1,713 shares of Amgen worth $620K as of Q2 2026.
  • Cromwell Holdings bought 110 Amgen shares in Q2 2026, an estimated $37.7K.
  • Amgen made up 0.28% of Cromwell Holdings's portfolio in Q2 2026, its #63 holding.
  • Cromwell Holdings first reported a position in Amgen in Q2 2024 and has held it in 9 quarters since.
  • 937 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Cromwell Holdings's 13F filing for Q2 2026, filed 14 Jul 2026.